Sunshine Biopharma Stock Quote SBFM - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.858

Bid

0.8566

Ask

0.862

Volume

4,994,404

0.81 Day's Range 0.9227

0.75 52 Week Range 140.00

Market Cap

21.57M

Previous Close

0.8375

Open

0.9227

Last Trade

0.8579

Last Trade Time

Financial Volume

$ 4,246,336

VWAP

0.850219

Average Volume (3m)

27,183,078

Shares Outstanding

25,678,290

Dividend Yield

PE Ratio

-4.79

Earnings Per Share (EPS)

-0.18

Revenue

24.09M

Net Profit

-4.51M

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of ... Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). Show more

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.sunshinebiopharma.com

Headquarters

Montreal, Quebec, Can

Founded

1970

Sunshine Biopharma Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker SBFM. The last closing price for Sunshine Biopharma was $0.84. Over the last year, Sunshine Biopharma shares have traded in a share price range of $ 0.75 to $ 140.00.

Sunshine Biopharma currently has 25,678,290 shares outstanding. The market capitalization of Sunshine Biopharma is $21.57 million. Sunshine Biopharma has a price to earnings ratio (PE ratio) of -4.79.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.086	11.1398963731	0.772	1.19	0.7531	10018302	0.91876298	CS
4	-9.142	-91.42	10	12.4	0.75	11361318	4.91437483	CS
12	-23.552	-96.4850471118	24.41	24.41	0.75	27183078	7.88990504	CS
26	-27.142	-96.9357142857	28	32	0.75	12829342	8.04779166	CS
52	-58.142	-98.5457627119	59	140	0.75	6736282	12.04413273	CS
156	-274.142	-99.688	275	987	0.75	4571180	170.67870027	CS
260	-274.142	-99.688	275	987	0.75	4571180	170.67870027	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BENFBeneficient	$ 6.8001 (254.17%)	31.01M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M
SHOTWSafety Shot Inc	$ 0.45 (45.16%)	644
AIPArteris Inc	$ 8.185 (38.03%)	1.11M
RGFReal Good Food Company Inc	$ 0.85 (37.32%)	4.26M
MNDRMobile health Network Solutions	$ 3.33 (-84.91%)	18.76M
NUVOHoldco Nuvo Group DG Ltd	$ 2.00 (-57.54%)	1.04M
SPTSprout Social Inc	$ 28.82 (-40.15%)	13.47M
UNITUniti Group Inc	$ 4.441 (-26.35%)	21.07M
IPDNProfessional Diversity Network Inc	$ 1.29 (-24.12%)	662.59k
AAPLApple Inc	$ 183.38 (5.98%)	163.22M
SQQQProShares UltraPro Short QQQ	$ 11.08 (-5.94%)	154.59M
JAGXJaguar Health Inc	$ 0.3164 (7.91%)	142.47M
NKLANikola Corporation	$ 0.6526 (6.55%)	106.88M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M